 |
|
Dr. Steffen Goletz, Ph.D.,
Chief Executive Officer / Chief Scientific Officer
Dr. Steffen Goletz, co-founder of GLYCOTOPE, was trained in biology, biochemistry and molecular biology at the universities in Heidelberg, Kaiserslautern, Manchester (UK) and Berlin and holds a Ph.D. in biochemistry. During his scientific career he worked in renowned research institutions including the Max-Delbrück-Centre for Molecular Medicine (Berlin), the MRC Centre for Protein Engineering (Cambridge, UK), and the German Cancer Research Centre in Heidelberg. Dr. Goletz is specialized in glycobiology, tumor immunology, antibody engineering and cellular engineering. He is also co-founder of the immunotherapeutic product company NEMOD Biotherapeutics GmbH & Co. KG where he achieved as CSO the successful preclinical development from concept to the clinical pipeline of two anti-cancer products during the last four years.
|